Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MCK 
McKesson Corporation (MCK)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/12/2025: MCK (3-star) is a STRONG-BUY. BUY since 36 days. Simulated Profits (10.54%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
17 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $929.36
1 Year Target Price $929.36
| 10 | Strong Buy |
| 3 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 58.26% | Avg. Invested days 70 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/12/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 103.77B USD | Price to earnings Ratio 26.31 | 1Y Target Price 929.36 |
Price to earnings Ratio 26.31 | 1Y Target Price 929.36 | ||
Volume (30-day avg) 17 | Beta 0.39 | 52 Weeks Range 556.30 - 867.63 | Updated Date 11/12/2025 |
52 Weeks Range 556.30 - 867.63 | Updated Date 11/12/2025 | ||
Dividends yield (FY) 0.34% | Basic EPS (TTM) 31.95 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-05 | When After Market | Estimate 8.79 | Actual 9.86 |
Profitability
Profit Margin 1.04% | Operating Margin (TTM) 1.37% |
Management Effectiveness
Return on Assets (TTM) 4.78% | Return on Equity (TTM) - |
Valuation
Trailing PE 26.31 | Forward PE 22.37 | Enterprise Value 111495520126 | Price to Sales(TTM) 0.27 |
Enterprise Value 111495520126 | Price to Sales(TTM) 0.27 | ||
Enterprise Value to Revenue 0.29 | Enterprise Value to EBITDA 18.37 | Shares Outstanding 123426650 | Shares Floating 123255087 |
Shares Outstanding 123426650 | Shares Floating 123255087 | ||
Percent Insiders 0.03 | Percent Institutions 90.37 |
Upturn AI SWOT
McKesson Corporation
Company Overview
History and Background
Founded in 1833, McKesson Corporation is one of the oldest and largest healthcare companies in the U.S. Initially a drug importing business, it expanded through acquisitions and innovation to become a leading distributor of pharmaceuticals and healthcare solutions.
Core Business Areas
- U.S. Pharmaceutical: Distributes branded, generic, specialty, and over-the-counter pharmaceuticals and other healthcare-related products.
- International: Provides pharmaceutical distribution and services internationally, primarily in Europe and Canada.
- Medical-Surgical Solutions: Offers medical supplies, equipment, and related services to healthcare providers.
Leadership and Structure
Brian S. Tyler is the CEO. McKesson operates with a corporate structure divided into business segments, each headed by senior leadership and overseen by the Board of Directors.
Top Products and Market Share
Key Offerings
- Pharmaceutical Distribution: Distributes a wide range of pharmaceuticals. McKesson is one of the largest pharmaceutical distributors in the U.S. alongside Cencora and Cardinal Health, with a significant portion of the market share. Competitors are Cencora (COR) and Cardinal Health (CAH).
- Medical Supplies: Supplies medical-surgical equipment and supplies to healthcare providers. Competitors in this market include Medline Industries and Owens & Minor (OMI).
- Specialty Pharmacy: Provides specialty pharmacy services for patients with chronic and complex conditions. Competitors include CVS Health (CVS) and Walgreens Boots Alliance (WBA).
Market Dynamics
Industry Overview
The pharmaceutical distribution and healthcare solutions industry is characterized by consolidation, regulatory changes, and increasing demand for efficient supply chains and cost-effective solutions.
Positioning
McKesson holds a leading position in pharmaceutical distribution and medical supplies, leveraging its scale and distribution network to offer competitive pricing and comprehensive services. Its competitive advantages include its extensive distribution network and longstanding relationships with manufacturers and providers.
Total Addressable Market (TAM)
The global pharmaceutical distribution market is estimated to be over $1 trillion. McKesson is positioned to capture a significant share of this market through its diverse services and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Large distribution network
- Strong relationships with manufacturers
- Diversified product and service offerings
- Established market presence
- Strong brand reputation
Weaknesses
- Exposure to regulatory changes
- Dependence on pharmaceutical manufacturers
- Potential for supply chain disruptions
- Litigation risks
- Intense competition
Opportunities
- Expansion into emerging markets
- Growth in specialty pharmacy services
- Increased demand for healthcare technology solutions
- Strategic acquisitions
- Advancements in digital healthcare.
Threats
- Pricing pressures from payers
- Competition from online pharmacies
- Regulatory scrutiny
- Economic downturns
- Generic drug pricing trends
Competitors and Market Share
Key Competitors
- COR
- CAH
- WBA
- CVS
Competitive Landscape
McKesson competes on price, service, and product breadth. It maintains an advantage through its scale and distribution network, but faces pressure from competitors focusing on specialized services and emerging technologies.
Major Acquisitions
Rx Savings Solutions
- Year: 2021
- Acquisition Price (USD millions): 600
- Strategic Rationale: Enhanced technology platform for prescription savings programs to help patients save on prescription costs.
Growth Trajectory and Initiatives
Historical Growth: McKesson has experienced steady growth in revenue and earnings, driven by acquisitions and organic expansion of its core businesses.
Future Projections: Analysts project continued growth in revenue and earnings, driven by favorable industry trends and McKesson's strategic initiatives.
Recent Initiatives: Recent initiatives include investments in healthcare technology, expansion of specialty pharmacy services, and strategic acquisitions to strengthen its market position.
Summary
McKesson is a strong player in the pharmaceutical distribution industry, benefiting from its extensive network and diversified offerings. Regulatory challenges and competitive pressures exist, but strategic initiatives and growth in specialty pharmacy present opportunities. Future growth depends on effectively navigating these challenges and capitalizing on emerging trends. The company's financial performance is stable, and management demonstrates acumen in steering its strategy for the next few years.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Investor Presentations
- Analyst Reports
- Industry Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share figures are estimates and may vary based on different sources and methodologies.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About McKesson Corporation
Exchange NYSE | Headquaters Irving, TX, United States | ||
IPO Launch date 1994-11-15 | CEO & Director Mr. Brian S. Tyler Ph.D. | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 43000 | Website https://www.mckesson.com |
Full time employees 43000 | Website https://www.mckesson.com | ||
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers deliver medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.